AU2017211858B2 - Differentiation of cortical neurons from human pluripotent stem cells - Google Patents

Differentiation of cortical neurons from human pluripotent stem cells Download PDF

Info

Publication number
AU2017211858B2
AU2017211858B2 AU2017211858A AU2017211858A AU2017211858B2 AU 2017211858 B2 AU2017211858 B2 AU 2017211858B2 AU 2017211858 A AU2017211858 A AU 2017211858A AU 2017211858 A AU2017211858 A AU 2017211858A AU 2017211858 B2 AU2017211858 B2 AU 2017211858B2
Authority
AU
Australia
Prior art keywords
inhibitor
signaling
cells
stem cells
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2017211858A
Other languages
English (en)
Other versions
AU2017211858A1 (en
Inventor
Yuchen Qi
Lorenz Studer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of AU2017211858A1 publication Critical patent/AU2017211858A1/en
Assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER reassignment MEMORIAL SLOAN-KETTERING CANCER CENTER Request for Assignment Assignors: MEMORIAL SLOAN-KETTERING CANCER CENTER, QI, YUCHEN, STUDER, LORENZ
Application granted granted Critical
Publication of AU2017211858B2 publication Critical patent/AU2017211858B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AU2017211858A 2016-01-27 2017-01-27 Differentiation of cortical neurons from human pluripotent stem cells Expired - Fee Related AU2017211858B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662287821P 2016-01-27 2016-01-27
US62/287,821 2016-01-27
US201762449488P 2017-01-23 2017-01-23
US62/449,488 2017-01-23
PCT/US2017/015480 WO2017132596A1 (en) 2016-01-27 2017-01-27 Differentiation of cortical neurons from human pluripotent stem cells

Publications (2)

Publication Number Publication Date
AU2017211858A1 AU2017211858A1 (en) 2018-09-13
AU2017211858B2 true AU2017211858B2 (en) 2023-05-18

Family

ID=59398774

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017211858A Expired - Fee Related AU2017211858B2 (en) 2016-01-27 2017-01-27 Differentiation of cortical neurons from human pluripotent stem cells

Country Status (8)

Country Link
US (2) US20180346875A1 (https=)
EP (1) EP3448985A4 (https=)
JP (2) JP7196376B2 (https=)
KR (1) KR20190035600A (https=)
AU (1) AU2017211858B2 (https=)
CA (1) CA3013054A1 (https=)
IL (1) IL260824A (https=)
WO (1) WO2017132596A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180105236A (ko) * 2016-02-05 2018-09-27 메모리얼 슬로안-케터링 캔서 센터 줄기 세포-유래 외배엽 계통 전구체의 분화 방법
WO2017173064A1 (en) 2016-03-30 2017-10-05 Asterias Biotherapeutics, Inc. Oligodendrocyte progenitor cell compositions
CN108359638B (zh) * 2018-04-04 2020-02-14 浙江霍德生物工程有限公司 功能大脑皮层细胞的诱导分化方法
US12365872B2 (en) 2018-09-19 2025-07-22 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture
KR20260020476A (ko) * 2019-01-23 2026-02-11 아스테리아스 바이오세라퓨틱스, 인크. 인간 만능 줄기 세포로부터의 배측-유래된 희소돌기아교세포 전구 세포
AU2020263484B2 (en) * 2019-04-24 2026-04-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nociceptor differentiation from human pluripotent stem cells
JP7810357B2 (ja) * 2019-07-25 2026-02-03 ザ スクリプス リサーチ インスティテュート ドーパミン作動性ニューロン及び前駆細胞を特定する方法
WO2022020798A1 (en) * 2020-07-24 2022-01-27 The Scripps Research Institute Methods of differentiating neurons and identification of disease phenotypes thereof
CN112553160B (zh) * 2020-12-25 2023-10-27 武汉睿健医药科技有限公司 一种化学诱导皮质神经元的方法及培养基
CA3204035A1 (en) * 2021-01-07 2022-07-14 Lorenz Studer Methods of generating cortical excitatory neurons
US12406510B2 (en) * 2021-03-26 2025-09-02 Howard University Method for the detection, segmentation and morphological mapping on neural cell images of the whole brain
CN115572712A (zh) * 2021-06-21 2023-01-06 香港再生医学有限公司 促使iPSC分化为中枢神经元细胞的方法及培养基和系统
MX2024004934A (es) * 2021-10-29 2024-09-10 Duke Univeristy Composiciones y sistemas para la edicion de celulas programables por arn y metodos para elaborar y usar los mismos.
WO2023104792A1 (en) 2021-12-07 2023-06-15 Vib Vzw Enhancers of neuronal maturation
CN118064356A (zh) * 2022-11-22 2024-05-24 浙江霍德生物工程有限公司 前脑神经前体细胞在治疗与前脑神经细胞的死亡和/或功能不全相关的疾病中的应用
US12565639B2 (en) 2023-06-13 2026-03-03 Aspen Neuroscience, Inc. Methods for differentiating dopaminergic neurons from stem cells
CN116970566B (zh) * 2023-09-22 2024-01-09 北京大学口腔医学院 诱导间充质干细胞神经分化的方法、神经干细胞及用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110002897A1 (en) * 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
WO2014176606A1 (en) * 2013-04-26 2014-10-30 Memorial Sloan-Kettering Center Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2009148170A1 (ja) 2008-06-06 2011-11-04 独立行政法人理化学研究所 幹細胞の培養方法
DK3578988T3 (da) * 2010-05-25 2025-02-24 Memorial Sloan Kettering Cancer Center Fremgangsmåde til nociceptordifferentiering af humane embryonale stamceller og anvendelse heraf
US20150329821A1 (en) * 2012-10-19 2015-11-19 Agency For Science, Technology And Research Methods of differentiating stem cells into one or more cell lineages
EP2951290B1 (en) 2013-02-01 2017-11-29 The United States of America, as represented by The Secretary, Department of Health and Human Services Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
ES2939807T3 (es) * 2014-03-21 2023-04-27 Fujifilm Cellular Dynamics Inc Producción de neuronas dopaminérgicas del mesencéfalo y métodos para su utilización

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110002897A1 (en) * 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
WO2014176606A1 (en) * 2013-04-26 2014-10-30 Memorial Sloan-Kettering Center Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells

Also Published As

Publication number Publication date
KR20190035600A (ko) 2019-04-03
JP7196376B2 (ja) 2022-12-27
EP3448985A4 (en) 2019-08-21
AU2017211858A1 (en) 2018-09-13
IL260824A (en) 2018-10-31
EP3448985A1 (en) 2019-03-06
JP2023011944A (ja) 2023-01-24
CA3013054A1 (en) 2017-08-03
WO2017132596A1 (en) 2017-08-03
US20180346875A1 (en) 2018-12-06
US20230323294A1 (en) 2023-10-12
JP2019506901A (ja) 2019-03-14

Similar Documents

Publication Publication Date Title
US20230323294A1 (en) Differentiation of cortical neurons from human pluripotent stem cells
Qi et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells
JP6756786B2 (ja) 移植用中脳ドーパミン（ｄａ）ニューロン
ES2747803T3 (es) Método de diferenciación a nociceptores de células madre embrionarias humanas y sus usos
EP3047017B1 (en) Methods of mammalian retinal stem cell production and applications
JP2022123137A (ja) ヒト多能性幹細胞からの機能的頭蓋プラコード派生体の特定
JP7471084B2 (ja) 幹細胞由来星状細胞、作製方法および使用方法
EP3683304A1 (en) Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter
CA3152522A1 (en) Methods of generating and isolating midbrain dopamine neurons
Corti Uncoupling Tumorigenicity from Dopaminergic Differentiation Potential of HiPSCs by Acting on Glypican4: Combining in Vitro Differentiation Studies with Preclinical Studies for Parkinson's Disease Therapy
HK40061521A (en) Midbrain dopamine (da) neurons for engraftment
WO2025003393A1 (en) Enhancing neuronal differentiation of neural progenitor cells
JP2026511969A (ja) Ｒｐｅ細胞を分化させるための組成物及び方法
HK40062512A (en) Midbrain dopamine (da) neurons for engraftment
HK40035880A (en) Midbrain dopamine (da) neurons for engraftment
Joy Directed differentiation of human pluripotent stem cells to telencephalic lateral ganglionic eminence progenitors using small molecules
Driehaus Regionalisation of human ES cell derived neural precursors
HK40029697A (en) Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter
HK1201879B (en) Midbrain dopamine (da) neurons for engraftment

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: MEMORIAL SLOAN-KETTERING CANCER CENTER

Free format text: FORMER APPLICANT(S): STUDER, LORENZ; QI, YUCHEN; MEMORIAL SLOAN-KETTERING CANCER CENTER

MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee